Impact of conversion surgery on survival in locally advanced pancreatic cancer patients treated with FOLFIRINOX chemotherapy-Reference-Cited by-同舟云学术

Impact of conversion surgery on survival in locally advanced pancreatic cancer patients treated with FOLFIRINOX chemotherapy

Published:2021-10-06 Issue: Volume: Page:
ISSN:1868-6974
Container-title:Journal of Hepato-Biliary-Pancreatic Sciences
language:en
Short-container-title:J Hepatobiliary Pancreat Sci

Author:

Lee Mirang¹^ORCID,Kang Jae Seung¹^ORCID,Kim Hongbeom¹,Kwon Wooil¹,Lee Sang Hyub²,Ryu Ji Kon²^ORCID,Kim Yong‐Tae²,Oh Do‐Youn²,Chie Eui Kyu³,Jang Jin‐Young¹

Affiliation:

1. Department of Surgery and Cancer Research Institute Seoul National University College of Medicine Seoul Republic of Korea

2. Department of Internal Medicine Seoul National University College of Medicine Seoul Republic of Korea

3. Department of Radiation Oncology Seoul National University College of Medicine Seoul Republic of Korea

Publisher

Wiley

Subject

Hepatology,Surgery

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jhbp.1050

Reference30 articles.

1. Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States

2. The Role of Location of Tumor in the Prognosis of the Pancreatic Cancer

3. Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages

4. Recent treatment patterns and survival outcomes in pancreatic cancer according to clinical stage based on single-center large-cohort data

5. Comparison of Clinical Outcomes of Borderline Resectable Pancreatic Cancer According to the Neoadjuvant Chemo-Regimens: Gemcitabine versus FOLFIRINOX

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after FOLFIRINOX or gemcitabine plus nab‐paclitaxel chemotherapy: A multicenter retrospective cohort study (PC‐CURE‐1);Journal of Hepato-Biliary-Pancreatic Sciences;2024-08-16

2. Re‐evaluation of risk and oncological outcomes of resection of veins and arteries in the resection of pancreatic cancer;Journal of Hepato-Biliary-Pancreatic Sciences;2024-07-14

3. Pretherapeutic factors predicting conversion surgery in unresectable pancreatic ductal adenocarcinoma: A retrospective study;Oncology Letters;2024-02-22

4. Advances in the management of pancreatic cancer;BMJ;2023-12-13

5. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer;Nature Reviews Gastroenterology & Hepatology;2023-11-30